Remission in psoriatic arthritis: Is it possible and how can it be predicted?

10.1186/ar3021

Saved in:

Bibliographic Details
Main Authors:	Saber, T.P, Ng, C.T, Renard, G, Lynch, B.M, Pontifex, E, Walsh, C.A.E, Grier, A, Molloy, M, Bresnihan, B, FitzGerald, O, Fearon, U, Veale, D.J
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2020
Subjects:	adalimumab C reactive protein disease modifying antirheumatic drug etanercept infliximab methotrexate steroid immunoglobulin G monoclonal antibody TNFR Fc fusion protein TNFR-Fc fusion protein tumor necrosis factor alpha tumor necrosis factor receptor adolescent adult aged arthropathy article controlled study demography female Health Assessment Questionnaire human joint swelling joint tenderness major clinical study male morning stiffness outcome assessment pain assessment prediction prospective study psoriatic arthritis remission rheumatoid arthritis steroid therapy treatment response visual analog scale cohort analysis disease course drug antagonism health survey metabolism middle aged predictive value retrospective study statistical model Adolescent Adult Aged Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Arthritis, Psoriatic Arthritis, Rheumatoid C-Reactive Protein Cohort Studies Disease Progression Female Health Surveys Humans Immunoglobulin G Linear Models Male Middle Aged Outcome Assessment (Health Care) Predictive Value of Tests Prospective Studies Receptors, Tumor Necrosis Factor Remission Induction Retrospective Studies Tumor Necrosis Factor-alpha Young Adult
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181668
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-181668
record_format	dspace
spelling	sg-nus-scholar.10635-1816682023-08-07T09:35:18Z Remission in psoriatic arthritis: Is it possible and how can it be predicted? Saber, T.P Ng, C.T Renard, G Lynch, B.M Pontifex, E Walsh, C.A.E Grier, A Molloy, M Bresnihan, B FitzGerald, O Fearon, U Veale, D.J DUKE-NUS MEDICAL SCHOOL adalimumab C reactive protein disease modifying antirheumatic drug etanercept infliximab methotrexate steroid adalimumab C reactive protein immunoglobulin G infliximab monoclonal antibody TNFR Fc fusion protein TNFR-Fc fusion protein tumor necrosis factor alpha tumor necrosis factor receptor adolescent adult aged arthropathy article controlled study demography female Health Assessment Questionnaire human joint swelling joint tenderness major clinical study male morning stiffness outcome assessment pain assessment prediction prospective study psoriatic arthritis remission rheumatoid arthritis steroid therapy treatment response visual analog scale cohort analysis disease course drug antagonism health survey metabolism middle aged predictive value retrospective study statistical model Adolescent Adult Aged Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Arthritis, Psoriatic Arthritis, Rheumatoid C-Reactive Protein Cohort Studies Disease Progression Female Health Surveys Humans Immunoglobulin G Linear Models Male Middle Aged Outcome Assessment (Health Care) Predictive Value of Tests Prospective Studies Receptors, Tumor Necrosis Factor Remission Induction Retrospective Studies Tumor Necrosis Factor-alpha Young Adult 10.1186/ar3021 Arthritis Research and Therapy 12 3 R94 2020-10-27T11:38:59Z 2020-10-27T11:38:59Z 2010 Article Saber, T.P, Ng, C.T, Renard, G, Lynch, B.M, Pontifex, E, Walsh, C.A.E, Grier, A, Molloy, M, Bresnihan, B, FitzGerald, O, Fearon, U, Veale, D.J (2010). Remission in psoriatic arthritis: Is it possible and how can it be predicted?. Arthritis Research and Therapy 12 (3) : R94. ScholarBank@NUS Repository. https://doi.org/10.1186/ar3021 14786354 https://scholarbank.nus.edu.sg/handle/10635/181668 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	adalimumab C reactive protein disease modifying antirheumatic drug etanercept infliximab methotrexate steroid adalimumab C reactive protein immunoglobulin G infliximab monoclonal antibody TNFR Fc fusion protein TNFR-Fc fusion protein tumor necrosis factor alpha tumor necrosis factor receptor adolescent adult aged arthropathy article controlled study demography female Health Assessment Questionnaire human joint swelling joint tenderness major clinical study male morning stiffness outcome assessment pain assessment prediction prospective study psoriatic arthritis remission rheumatoid arthritis steroid therapy treatment response visual analog scale cohort analysis disease course drug antagonism health survey metabolism middle aged predictive value retrospective study statistical model Adolescent Adult Aged Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Arthritis, Psoriatic Arthritis, Rheumatoid C-Reactive Protein Cohort Studies Disease Progression Female Health Surveys Humans Immunoglobulin G Linear Models Male Middle Aged Outcome Assessment (Health Care) Predictive Value of Tests Prospective Studies Receptors, Tumor Necrosis Factor Remission Induction Retrospective Studies Tumor Necrosis Factor-alpha Young Adult
spellingShingle	adalimumab C reactive protein disease modifying antirheumatic drug etanercept infliximab methotrexate steroid adalimumab C reactive protein immunoglobulin G infliximab monoclonal antibody TNFR Fc fusion protein TNFR-Fc fusion protein tumor necrosis factor alpha tumor necrosis factor receptor adolescent adult aged arthropathy article controlled study demography female Health Assessment Questionnaire human joint swelling joint tenderness major clinical study male morning stiffness outcome assessment pain assessment prediction prospective study psoriatic arthritis remission rheumatoid arthritis steroid therapy treatment response visual analog scale cohort analysis disease course drug antagonism health survey metabolism middle aged predictive value retrospective study statistical model Adolescent Adult Aged Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Arthritis, Psoriatic Arthritis, Rheumatoid C-Reactive Protein Cohort Studies Disease Progression Female Health Surveys Humans Immunoglobulin G Linear Models Male Middle Aged Outcome Assessment (Health Care) Predictive Value of Tests Prospective Studies Receptors, Tumor Necrosis Factor Remission Induction Retrospective Studies Tumor Necrosis Factor-alpha Young Adult Saber, T.P Ng, C.T Renard, G Lynch, B.M Pontifex, E Walsh, C.A.E Grier, A Molloy, M Bresnihan, B FitzGerald, O Fearon, U Veale, D.J Remission in psoriatic arthritis: Is it possible and how can it be predicted?
description	10.1186/ar3021
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Saber, T.P Ng, C.T Renard, G Lynch, B.M Pontifex, E Walsh, C.A.E Grier, A Molloy, M Bresnihan, B FitzGerald, O Fearon, U Veale, D.J
format	Article
author	Saber, T.P Ng, C.T Renard, G Lynch, B.M Pontifex, E Walsh, C.A.E Grier, A Molloy, M Bresnihan, B FitzGerald, O Fearon, U Veale, D.J
author_sort	Saber, T.P
title	Remission in psoriatic arthritis: Is it possible and how can it be predicted?
title_short	Remission in psoriatic arthritis: Is it possible and how can it be predicted?
title_full	Remission in psoriatic arthritis: Is it possible and how can it be predicted?
title_fullStr	Remission in psoriatic arthritis: Is it possible and how can it be predicted?
title_full_unstemmed	Remission in psoriatic arthritis: Is it possible and how can it be predicted?
title_sort	remission in psoriatic arthritis: is it possible and how can it be predicted?
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/181668
_version_	1779152860078931968

Remission in psoriatic arthritis: Is it possible and how can it be predicted?

Similar Items